newsfilter
← Latest News
PR Newswire·

Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling

Collaboration will comprehensively profile DNA, RNA and proteins on patient samples from the Phase 2 Maverick trial to understand mechanisms of disease response and resistance IRVING, Texas and SAN DIEGO, June 2, 2022 /PRNewswire/ -- Caris Life Scienc